Literature DB >> 7902838

Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments.

J W Weisel1, C W Francis, C Nagaswami, V J Marder.   

Abstract

After fibrin polymerizes to form a clot, the transglutaminase Factor XIIIa cross-links the gamma and alpha chains to stabilize the clot. There has been conflicting evidence on whether the gamma chain isopeptide bonds occur between molecules that are interacting in a longitudinal (end-to-end) manner or transverse (half-staggered) manner between the two strands of the protofibril. Since the topology of the cross-links has important consequences for fibrin structure, as well as for its stability and susceptibility to and pattern of fibrinolysis, cross-linked fibrin fragments were examined by electron microscopy to distinguish between these two possibilities for the arrangement of the ligated molecules. Cross-linked fibrin clots were produced by prolonged incubation of fibrinogen with thrombin and Factor XIII, and then digested with plasmin. The resulting soluble cross-linked fibrin complexes were rotary-shadowed with tungsten and examined by electron microscopy, revealing protofibril-like structures consisting of clusters of globular domains with a repeat of 22.5 nm. Longer plasmin digestion times yielded increasingly shorter structures. Rotary-shadowed cross-linked fibrin fragments, produced by dilution of the complexes into 0.125% acetic acid at pH 3.5 to dissociate all non-covalently linked fragments, showed uniformly single-stranded structures with a characteristic spacing of nodules, consistent with longitudinal cross-linking. Long, thin strands were seen at short digestion times, while shorter strands appeared with longer digestion. The smallest structures observed included two nodules together, and two such nodules with another nodule at a short distance from one or both ends, compatible with fragments DD, DY, and YY. Longer strands had the appearance of fibrin molecules that were linked end-to-end, usually with a fragment D or Y at each end. In conclusion, these results are consistent with previously proposed structures of these derivatives and clearly demonstrate that the interactions between cross-linked gamma chains are longitudinal (end-to-end) and not transverse.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902838

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Transglutaminase-catalyzed crosslinking of the Aalpha and gamma constituent chains in fibrinogen.

Authors:  S N Murthy; J H Wilson; T J Lukas; Y Veklich; J W Weisel; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Longitudinal orientation of cross-linked polypeptide γ chains in fibrin fibrils.

Authors:  M A Rosenfeld; V B Leonova; A V Bychkova; E A Kostanova; M I Biryukova
Journal:  Dokl Biochem Biophys       Date:  2015-10-31       Impact factor: 0.788

3.  Ligneous conjunctivitis: biochemical evidence for hypofibrinolysis.

Authors:  M L Ramsby; P C Donshik; G S Makowski
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

4.  The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.

Authors:  Y Veklich; E K Ang; L Lorand; J W Weisel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology.

Authors:  E A Ryan; L F Mockros; A M Stern; L Lorand
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

6.  Structural Basis of Interfacial Flexibility in Fibrin Oligomers.

Authors:  Artem Zhmurov; Anna D Protopopova; Rustem I Litvinov; Pavel Zhukov; Alexander R Mukhitov; John W Weisel; Valeri Barsegov
Journal:  Structure       Date:  2016-09-29       Impact factor: 5.006

Review 7.  Thrombin generation, fibrin clot formation and hemostasis.

Authors:  Alisa S Wolberg; Robert A Campbell
Journal:  Transfus Apher Sci       Date:  2008-02-20       Impact factor: 1.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.